A3E (p.Ala3Glu) variant of NF1 (Neurofibromin)
A3E (p.Ala3Glu) in NF1 (Neurofibromin) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data, published literature, and structural context.
A3E (p.Ala3Glu) variant details
- p.Ala3Glu
- rs1911550821
- ClinGen CA398979177
- ClinVar RCV002376340
- Uncertain significance
- Missense
- Variant Prioritization Score for Impact Estimate 0.349
- REVEL 0.13
- AlphaMissense 0.58
- MetaLR 0.06
- MetaSVM -1.14
- CADD 23.10
- PolyPhen-2 0.68
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Population evidence available
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)